(Q43799878)

26 November 2017

title

Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA. (English)

1 reference

26 November 2017

1 reference

Yee RE

1

1 reference

26 November 2017

Cheng DW

2

1 reference

26 November 2017

Huang SC

3

1 reference

26 November 2017

Namavari M

4

1 reference

26 November 2017

Satyamurthy N

5

1 reference

26 November 2017

Barrio JR

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 November 2017

published in

Biochemical Pharmacology

1 reference

26 November 2017

volume

62

1 reference

26 November 2017

issue

10

1 reference

26 November 2017

page(s)

1409-1415

1 reference

Striatal dopamine metabolism in living monkeys examined by positron emission tomography.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Dopamine visualized in the basal ganglia of living man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

4-[18F]fluoro-L-m-tyrosine: an L-3,4-dihydroxyphenylalanine analog for probing presynaptic dopaminergic function with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Radiofluorinated L-m-tyrosines: new in-vivo probes for central dopamine biochemistry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Mapping cocaine binding sites in human and baboon brain in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

6-18F-L-dopa imaging of the dopamine neostriatal system in normal and clinically normal MPTP-treated rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity in MPTP-treated squirrel monkeys: in vivo and in vitro investigations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

6-[18F]fluoro-L-dopa probes dopamine turnover rates in central dopaminergic structures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Modulation of retinal aromatic L-amino acid decarboxylase via alpha 2 adrenoceptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Inhibition of 3,4-dihydroxy-L-phenylalanine decarboxylase in rat striatal synaptosomes by amino acids interacting with substrate transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Studies on the enzymatic blood-brain barrier: Quantitative measurements of DOPA decarboxylase in the wall of microvessels as related to the parenchyma in various CNS regions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Routes of administration and effect of carbidopa pretreatment on 6-[18F]fluoro-L-dopa/PET scans in non-human primates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Remote, semiautomated production of 6-[18F]fluoro-L-dopa for human studies with PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Synthesis of 6-[18F] and 4-[18F]fluoro-L-m-tyrosines via regioselective radiofluorodestannylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Stereospecificity of blood-brain barrier permeability to amino acids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Rat brain regional uptake and decarboxylation of L-DOPA following carotid injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

PYRIDOXAL KINASE OF HUMAN BRAIN AND ITS INHIBITION BY HYDRAZINE DERIVATIVES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Inhibition of DOPA decarboxylase by the hydrazino analog of alpha-methylDOPA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Blood-brain barrier to carbidopa (MK-486) and Ro 4-4602, peripheral dopa decarboxylase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Quantitative determination of pyridoxal-phosphate by apotryptophanase of Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Effect of pyridoxine on the depletion of tissue pyridoxal phosphate by carbidopa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2801%2900787-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(01)00787-0

1 reference

26 November 2017

1 reference